Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

Ann Med Res. 2017; 24(4): 477-480


The evaluation of kidney biopsy results in the 6 years period: single center experience

Burak Sayin.




Abstract
Cited by 0 Articles

diseases. In our study, we aimed to evaluate the results of kidney biopsies that have been performed in the last 6 years.
Material and Methods: The results of 202 patients who underwent renal biopsy in our hospital between 2011 and 2017 were retrospectively evaluated.
Results: The mean age of the patients were found as 50.7 ± 15.1 years. The male and female numbers of the patients were 114 (56.4%) and 88 (44.6%) respectively. Proteinuria in 96 patients (47.5%) was the most common indication for kidney biopsy. When we evaluated the biopsy results; 123 (60.9%) of the patients were diagnosed for primary glomerulonephritis, 43 (21.3%) of the patients were diagnosed for secondary glomerulonephritis while 36 (17.8%) of the patients were diagnosed for tubulointerstitial involvement. The most common pathological diagnosis were Focal Segmental Glomerulosclerosis in 40 patients (19.8%) and Immune Globulin A Nephropathy in 38 patients (18.8%) in our patient group who had primary glomerulonephritis.
Conclusion: The most common pathology of the patients who had native kidney biopsy was primary glomerulonephritis. 61.3% of the patients who had diagnosis for Diabetes Mellitus had pathologies other than Diabetic Nephropathy shows the importance of screening any other co-existing pathologies in this group of patients. Uncontrolled use of the drugs accelerates the rate of Tubulointerstitial Nephritis as the primary and co-existing pathological diagnosis.

Key words: Renal Pathology; Primary; Secondary; Tubulointerstitial; Co-Existing.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.